SAGE — Sage Therapeutics Share News
0.000.00%
Last trade - 00:00- $544.97m
- $121.11m
- $41.24m
Sage Therapeutics Inc Reports Results For The Quarter Ended June 30: Earnings Summary
SAGE Therapeutics Q2 revenue rises sequentially
Brief: Supernus Pharmaceuticals Announces Expiration Of Hart-Scott-Rodino Waiting Period For Sage Therapeutics Tender Offer
Sage Therapeutics Inc Expected To Post A Loss Of 95 Cents A Share: Earnings Preview
U.S. RESEARCH ROUNDUP-Hershey, Metlife, Voya Financial
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Hinge Health, MNTN, Reddit
U.S. STOCKS ON THE MOVE-Eaton, Roku, PayPal
Sage Therapeutics jumps to over 10-month high after Supernus Pharma's buyout offer
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-EchoStar, T1 Energy, Smurfit Westrock
Sage Therapeutics jumps after Supernus Pharma's buyout offer
Brief: Supernus Pharmaceuticals To Acquire Sage Therapeutics, Strengthening Its Neuropsychiatry Product Portfolio
Supernus Pharma to acquire Sage Therapeutics in up to $795 million deal (updated)
Supernus Pharma to acquire Sage Therapeutics in up to $795 million deal
Sage Therapeutics Inc Reports Results For The Quarter Ended March 31: Earnings Summary
Sage Therapeutics Inc Expected To Post A Loss Of $1.02 A Share: Earnings Preview
Brief: SAGE Therapeutics Announces Research And Development Leadership Transition
Sage Therapeutics Inc Reports Results For The Quarter Ended December 31: Earnings Summary